Drug Abuse Treatment Market - Trends, Size & Outlook (2024-2032)

Drug Abuse Treatment Market Synopsis:

Drug Abuse Treatment Market Size Was Valued at USD 17522.98 Million in 2023, and is Projected to Reach USD 30,789.79 Million by 2032, Growing at a CAGR of 7.9% From 2024-2032.

The Drug Abuse Treatment Market is on the processes of treating people with substance use disorders and depends on nature of the substance which includes opioids, alcohol and other drugs. This market contains behaviour therapy, detoxification services, medication assisted treatment (MAT) and rehabilitation services. As the cases of substance abuse disorder increase worldwide and the facts show that the majority of cases occur in the developed countries the need for effective solutions also increases. With governments and healthcare organizations continuing to find ways to battle the opiate and other substance abuse issues, this market is expected to grow.

The most pressing growth factor to stimulate demand for Drug Abuse Treatment Market is the rising prevalence of dependence on substances in people due to various factors which include but are not limited to mental health disorders, stress levels, and easy access to substance use. These advancements are high-tech solutions, digital therapeutics, telemedicine and the development of many novel approaches has served to give a fillip to the market. Specifically, medication assisted treatments, where using medications such as methadone or buprenorphine temporally substitutes for the opioid and combining it with counseling and behavioral therapies has been highly effective on opioid addiction therefore raising the d likewise.

But this same market is going to be threatened by factors like social disgrace to drug addiction, high cost of some programs and areas, or lack of adequate health care in some geographical areas. However, there still remains some challenges which inhibit market advancement, but strong awareness, innovative government policies, and favourable legislation are supposed to stimulate further market development in the years to come. Further, collaborative relations between drugs and technology organizations to come up with more elaborate treatment approaches are opening up new prospects of the Drug Abuse Treatment Market.

Drug Abuse Treatment Market Trend Analysis:

Rise of Telemedicine in Drug Abuse Treatment

• Some of the trends observed in the Drug Abuse Treatment Market are telemedicine usage and digital platforms within the services’ delivery. As technologies adaptable for tele-medicine are being developed further, and given the consideration of the patient’s need, especially in rural or in areas with low access to health services, an increasing number of physicians use virtual consultative processes and digital treatments in cases of substance use disorders. This transition was even more amplified by the covid19 pandemic that afterwards increased the provision of substance use treatment through telemedicine. Since telemedicine services are delivered remotely, patients are comfortable and they also have the freedom to attend the sessionsrganized for them.

Increased Focus on Medication-Assisted Treatment (MAT)

• Another major trend is growing state and federal attention to the emergence of Medication-Assisted Treatment or MAT for treating opioid and alcohol use disorders. comprising of buprenorphine, methadone or naltrexone along with other behaviour therapies, MAT is a more integrated recovery system for addiction. It has been established that this method lowers the relapse rate as well as enhance long-term recovery. Evidently, as the use of opioids remains a serious problem in many areas, especially in North America, the need for MAT programs increases. These are the reasons why MAT is being embraced more and recommended to be made a standard of care in substance use disorders treatment as government support and funds are boosting the MAT programs.

Drug Abuse Treatment Market Segment Analysis:

Drug Abuse Treatment Market is Segmented on the basis of Types, Treatments, Routes of Administration, End-Users, Distribution Channel, and Region

By Types, Opioid Addiction segment is expected to dominate the market during the forecast period

• The Drug Abuse Treatment market can be divided by types of addiction such as opioid, benzodiazepine, barbiturate and others. The largest segment of addiction is opioid addiction stemming from the misuse of prescription opioids and illicit opioids, thus creating an enormous need for viable treatments such as MAT and counselling. It has attracted attention due to rising prescription rates and related dependency problems of benzodiazepine, which required physicians to adapt specific clinical utilization techniques. While barbiturate dependence is not as rampant today, it still requires individual attention because of probable severe withdrawal signs. The ‘other’ category consists of myriad substances such as stimulants and hallucinogens pointing out that drug abuse treatment and rehabilitation is a broad field where not one form of treatment can fit all because each type of ‘substance’ and type of dependency needs an individual treatment approach.

Distribution Channel, Retail Pharmacy segment expected to held the largest share

• In a greater context, distribution channels have a significant role of making drug abuse treatment available and accessible in the market for patients with substance use disorders. Inpatient pharmacies are essential offering of medical drugs and treatment services to patients within the health facilities especially to those being in the detoxification or health enhancement programs. There are retail pharmacies that can prescribe other medication and over the counter drugs, and counseling services to those who are affected in the community. Also, today the internet and especially the online pharmacies have brought the changes that patients can freely access the drugs and other treatment related help for substance dependence disorders while ensuring total anonymity and discretion. Additional distribution channels include drug treatment centers, support groups and other establishments continue to expand the range of solutions aimed at the treatment of patients increasing the treatment network for those in various stages of their recovery process.

Drug Abuse Treatment Market Regional Insights:

North America is dominating the market due to the focus of global players on novel technology or formulation of existing drugs.

North American region holds the largest share for Drug Abuse Treatment Market which is due to the new technologies that are being employed in this area and also new formulations of already available drugs with attempts to address Substance abuse disorders. Currently, leading US and Canadian pharmaceutical companies and healthcare providers are keen on research and development of treatments to involve long actioning formulas besides combination formulas that may improve patients compliance, thus have better results. Bearing this in mind, new trends in the demand for different treatments and, in particular, the spread of substance use disorders, including opioid use disorders, have led to an increasing level of government investments in treatment services. This focus on care and innovation also reflects on developing and improving the treatment approaches and the adoption of the new approaches to health in general like telemedicine and digital health care making North America leading in global approach to drug abuse treatment.

Active Key Players in the Drug Abuse Treatment Market:

• Takeda Pharmaceutical Company Limited (Japan)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Abbott (U.S.)
• Medtronic (Ireland)
• Abbott (U.S.)
• BD (U.S.)
• Johnson & Johnson Services, Inc.(U.S.)
• GSK Plc. (U.K.)
• Bayer AG (Germany)
• Zimmer Biomet (U.S.)
• Stryker Corporation (U.S.)
• Homology Medicines, Inc (U.S.)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• JCR Pharmaceuticals Co., Ltd. (Japan)
• Sangamo Therapeutics (U.S.)
• AVROBIO, Inc (U.S.)
• REGENXBIO Inc (U.S.)
• CANbridge Life Sciences Ltd. (Taiwan)
• Denali Therapeutics (U.S.)
• Jasper Therapeutics, Inc. (U.S.)
• Other Active Players

Chapter 1: Introduction
 1.1 Scope and Coverage

Chapter 2:Executive Summary

Chapter 3: Market Landscape
 3.1 Market Dynamics
  3.1.1 Drivers
  3.1.2 Restraints
  3.1.3 Opportunities
  3.1.4 Challenges
 3.2 Market Trend Analysis
 3.3 PESTLE Analysis
 3.4 Porter's Five Forces Analysis
 3.5 Industry Value Chain Analysis
 3.6 Ecosystem
 3.7 Regulatory Landscape
 3.8 Price Trend Analysis
 3.9 Patent Analysis
 3.10 Technology Evolution
 3.11 Investment Pockets
 3.12 Import-Export Analysis

Chapter 4: Drug Abuse Treatment Market by Types
 4.1 Drug Abuse Treatment Market Snapshot and Growth Engine
 4.2 Drug Abuse Treatment Market Overview
 4.3 Opioid Addiction
  4.3.1 Introduction and Market Overview
  4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.3.3 Key Market Trends, Growth Factors and Opportunities
  4.3.4 Opioid Addiction: Geographic Segmentation Analysis
 4.4 Benzodiazepine Addiction
  4.4.1 Introduction and Market Overview
  4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.4.3 Key Market Trends, Growth Factors and Opportunities
  4.4.4 Benzodiazepine Addiction: Geographic Segmentation Analysis
 4.5 Barbiturate Addiction and Others
  4.5.1 Introduction and Market Overview
  4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  4.5.3 Key Market Trends, Growth Factors and Opportunities
  4.5.4 Barbiturate Addiction and Others: Geographic Segmentation Analysis

Chapter 5: Drug Abuse Treatment Market by Treatment
 5.1 Drug Abuse Treatment Market Snapshot and Growth Engine
 5.2 Drug Abuse Treatment Market Overview
 5.3 Therapy
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Therapy: Geographic Segmentation Analysis
 5.4 Medication and Others
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Medication and Others: Geographic Segmentation Analysis

Chapter 6: Drug Abuse Treatment Market by Route of Administration
 6.1 Drug Abuse Treatment Market Snapshot and Growth Engine
 6.2 Drug Abuse Treatment Market Overview
 6.3 Oral
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Oral: Geographic Segmentation Analysis
 6.4 Parenteral
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Parenteral: Geographic Segmentation Analysis
 6.5 Others
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Others: Geographic Segmentation Analysis

Chapter 7: Drug Abuse Treatment Market by End-Users
 7.1 Drug Abuse Treatment Market Snapshot and Growth Engine
 7.2 Drug Abuse Treatment Market Overview
 7.3 Hospitals
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Hospitals: Geographic Segmentation Analysis
 7.4 Specialty Clinics
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Specialty Clinics: Geographic Segmentation Analysis
 7.5 Others
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 Others: Geographic Segmentation Analysis

Chapter 8: Drug Abuse Treatment Market by Distribution Channel
 8.1 Drug Abuse Treatment Market Snapshot and Growth Engine
 8.2 Drug Abuse Treatment Market Overview
 8.3 Hospital Pharmacy
  8.3.1 Introduction and Market Overview
  8.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.3.3 Key Market Trends, Growth Factors and Opportunities
  8.3.4 Hospital Pharmacy: Geographic Segmentation Analysis
 8.4 Retail Pharmacy
  8.4.1 Introduction and Market Overview
  8.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.4.3 Key Market Trends, Growth Factors and Opportunities
  8.4.4 Retail Pharmacy: Geographic Segmentation Analysis
 8.5 online Pharmacies and Others
  8.5.1 Introduction and Market Overview
  8.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
  8.5.3 Key Market Trends, Growth Factors and Opportunities
  8.5.4 online Pharmacies and Others: Geographic Segmentation Analysis

Chapter 9: Company Profiles and Competitive Analysis
 9.1 Competitive Landscape
  9.1.1 Competitive Benchmarking
  9.1.2 Drug Abuse Treatment Market Share by Manufacturer (2023)
  9.1.3 Industry BCG Matrix
  9.1.4 Heat Map Analysis
  9.1.5 Mergers and Acquisitions  
 9.2 TAKEDA PHARMACEUTICAL COMPANY LIMITED (JAPAN)
  9.2.1 Company Overview
  9.2.2 Key Executives
  9.2.3 Company Snapshot
  9.2.4 Role of the Company in the Market
  9.2.5 Sustainability and Social Responsibility
  9.2.6 Operating Business Segments
  9.2.7 Product Portfolio
  9.2.8 Business Performance
  9.2.9 Key Strategic Moves and Recent Developments
  9.2.10 SWOT Analysis
 9.3 F. HOFFMANN-LA ROCHE LTD (SWITZERLAND)
 9.4 ABBOTT (U.S.)
 9.5 MEDTRONIC (IRELAND)
 9.6 BD (U.S.)
 9.7 JOHNSON & JOHNSON SERVICES INC. (U.S.)
 9.8 GSK PLC. (U.K.)
 9.9 BAYER AG (GERMANY)
 9.10 ZIMMER BIOMET (U.S.)
 9.11 STRYKER CORPORATION (U.S.)
 9.12 HOMOLOGY MEDICINES INC. (U.S.)
 9.13 NOVARTIS AG (SWITZERLAND)
 9.14 PFIZER INC. (U.S.)
 9.15 JCR PHARMACEUTICALS CO. LTD. (JAPAN)
 9.16 SANGAMO THERAPEUTICS (U.S.)
 9.17 AVROBIO INC (U.S.)
 9.18 REGENXBIO INC (U.S.)
 9.19 CANBRIDGE LIFE SCIENCES LTD. (TAIWAN)
 9.20 DENALI THERAPEUTICS (U.S.)
 9.21 JASPER THERAPEUTICS INC. (U.S.)
 9.22 OTHER ACTIVE PLAYERS

Chapter 10: Global Drug Abuse Treatment Market By Region
 10.1 Overview
 10.2. North America Drug Abuse Treatment Market
  10.2.1 Key Market Trends, Growth Factors and Opportunities
  10.2.2 Top Key Companies
  10.2.3 Historic and Forecasted Market Size by Segments
  10.2.4 Historic and Forecasted Market Size By Types
  10.2.4.1 Opioid Addiction
  10.2.4.2 Benzodiazepine Addiction
  10.2.4.3 Barbiturate Addiction and Others
  10.2.5 Historic and Forecasted Market Size By Treatment
  10.2.5.1 Therapy
  10.2.5.2 Medication and Others
  10.2.6 Historic and Forecasted Market Size By Route of Administration
  10.2.6.1 Oral
  10.2.6.2 Parenteral
  10.2.6.3 Others
  10.2.7 Historic and Forecasted Market Size By End-Users
  10.2.7.1 Hospitals
  10.2.7.2 Specialty Clinics
  10.2.7.3 Others
  10.2.8 Historic and Forecasted Market Size By Distribution Channel
  10.2.8.1 Hospital Pharmacy
  10.2.8.2 Retail Pharmacy
  10.2.8.3 online Pharmacies and Others
  10.2.9 Historic and Forecast Market Size by Country
  10.2.9.1 US
  10.2.9.2 Canada
  10.2.9.3 Mexico
 10.3. Eastern Europe Drug Abuse Treatment Market
  10.3.1 Key Market Trends, Growth Factors and Opportunities
  10.3.2 Top Key Companies
  10.3.3 Historic and Forecasted Market Size by Segments
  10.3.4 Historic and Forecasted Market Size By Types
  10.3.4.1 Opioid Addiction
  10.3.4.2 Benzodiazepine Addiction
  10.3.4.3 Barbiturate Addiction and Others
  10.3.5 Historic and Forecasted Market Size By Treatment
  10.3.5.1 Therapy
  10.3.5.2 Medication and Others
  10.3.6 Historic and Forecasted Market Size By Route of Administration
  10.3.6.1 Oral
  10.3.6.2 Parenteral
  10.3.6.3 Others
  10.3.7 Historic and Forecasted Market Size By End-Users
  10.3.7.1 Hospitals
  10.3.7.2 Specialty Clinics
  10.3.7.3 Others
  10.3.8 Historic and Forecasted Market Size By Distribution Channel
  10.3.8.1 Hospital Pharmacy
  10.3.8.2 Retail Pharmacy
  10.3.8.3 online Pharmacies and Others
  10.3.9 Historic and Forecast Market Size by Country
  10.3.9.1 Russia
  10.3.9.2 Bulgaria
  10.3.9.3 The Czech Republic
  10.3.9.4 Hungary
  10.3.9.5 Poland
  10.3.9.6 Romania
  10.3.9.7 Rest of Eastern Europe
 10.4. Western Europe Drug Abuse Treatment Market
  10.4.1 Key Market Trends, Growth Factors and Opportunities
  10.4.2 Top Key Companies
  10.4.3 Historic and Forecasted Market Size by Segments
  10.4.4 Historic and Forecasted Market Size By Types
  10.4.4.1 Opioid Addiction
  10.4.4.2 Benzodiazepine Addiction
  10.4.4.3 Barbiturate Addiction and Others
  10.4.5 Historic and Forecasted Market Size By Treatment
  10.4.5.1 Therapy
  10.4.5.2 Medication and Others
  10.4.6 Historic and Forecasted Market Size By Route of Administration
  10.4.6.1 Oral
  10.4.6.2 Parenteral
  10.4.6.3 Others
  10.4.7 Historic and Forecasted Market Size By End-Users
  10.4.7.1 Hospitals
  10.4.7.2 Specialty Clinics
  10.4.7.3 Others
  10.4.8 Historic and Forecasted Market Size By Distribution Channel
  10.4.8.1 Hospital Pharmacy
  10.4.8.2 Retail Pharmacy
  10.4.8.3 online Pharmacies and Others
  10.4.9 Historic and Forecast Market Size by Country
  10.4.9.1 Germany
  10.4.9.2 UK
  10.4.9.3 France
  10.4.9.4 The Netherlands
  10.4.9.5 Italy
  10.4.9.6 Spain
  10.4.9.7 Rest of Western Europe
 10.5. Asia Pacific Drug Abuse Treatment Market
  10.5.1 Key Market Trends, Growth Factors and Opportunities
  10.5.2 Top Key Companies
  10.5.3 Historic and Forecasted Market Size by Segments
  10.5.4 Historic and Forecasted Market Size By Types
  10.5.4.1 Opioid Addiction
  10.5.4.2 Benzodiazepine Addiction
  10.5.4.3 Barbiturate Addiction and Others
  10.5.5 Historic and Forecasted Market Size By Treatment
  10.5.5.1 Therapy
  10.5.5.2 Medication and Others
  10.5.6 Historic and Forecasted Market Size By Route of Administration
  10.5.6.1 Oral
  10.5.6.2 Parenteral
  10.5.6.3 Others
  10.5.7 Historic and Forecasted Market Size By End-Users
  10.5.7.1 Hospitals
  10.5.7.2 Specialty Clinics
  10.5.7.3 Others
  10.5.8 Historic and Forecasted Market Size By Distribution Channel
  10.5.8.1 Hospital Pharmacy
  10.5.8.2 Retail Pharmacy
  10.5.8.3 online Pharmacies and Others
  10.5.9 Historic and Forecast Market Size by Country
  10.5.9.1 China
  10.5.9.2 India
  10.5.9.3 Japan
  10.5.9.4 South Korea
  10.5.9.5 Malaysia
  10.5.9.6 Thailand
  10.5.9.7 Vietnam
  10.5.9.8 The Philippines
  10.5.9.9 Australia
  10.5.9.10 New Zealand
  10.5.9.11 Rest of APAC
 10.6. Middle East & Africa Drug Abuse Treatment Market
  10.6.1 Key Market Trends, Growth Factors and Opportunities
  10.6.2 Top Key Companies
  10.6.3 Historic and Forecasted Market Size by Segments
  10.6.4 Historic and Forecasted Market Size By Types
  10.6.4.1 Opioid Addiction
  10.6.4.2 Benzodiazepine Addiction
  10.6.4.3 Barbiturate Addiction and Others
  10.6.5 Historic and Forecasted Market Size By Treatment
  10.6.5.1 Therapy
  10.6.5.2 Medication and Others
  10.6.6 Historic and Forecasted Market Size By Route of Administration
  10.6.6.1 Oral
  10.6.6.2 Parenteral
  10.6.6.3 Others
  10.6.7 Historic and Forecasted Market Size By End-Users
  10.6.7.1 Hospitals
  10.6.7.2 Specialty Clinics
  10.6.7.3 Others
  10.6.8 Historic and Forecasted Market Size By Distribution Channel
  10.6.8.1 Hospital Pharmacy
  10.6.8.2 Retail Pharmacy
  10.6.8.3 online Pharmacies and Others
  10.6.9 Historic and Forecast Market Size by Country
  10.6.9.1 Turkiye
  10.6.9.2 Bahrain
  10.6.9.3 Kuwait
  10.6.9.4 Saudi Arabia
  10.6.9.5 Qatar
  10.6.9.6 UAE
  10.6.9.7 Israel
  10.6.9.8 South Africa
 10.7. South America Drug Abuse Treatment Market
  10.7.1 Key Market Trends, Growth Factors and Opportunities
  10.7.2 Top Key Companies
  10.7.3 Historic and Forecasted Market Size by Segments
  10.7.4 Historic and Forecasted Market Size By Types
  10.7.4.1 Opioid Addiction
  10.7.4.2 Benzodiazepine Addiction
  10.7.4.3 Barbiturate Addiction and Others
  10.7.5 Historic and Forecasted Market Size By Treatment
  10.7.5.1 Therapy
  10.7.5.2 Medication and Others
  10.7.6 Historic and Forecasted Market Size By Route of Administration
  10.7.6.1 Oral
  10.7.6.2 Parenteral
  10.7.6.3 Others
  10.7.7 Historic and Forecasted Market Size By End-Users
  10.7.7.1 Hospitals
  10.7.7.2 Specialty Clinics
  10.7.7.3 Others
  10.7.8 Historic and Forecasted Market Size By Distribution Channel
  10.7.8.1 Hospital Pharmacy
  10.7.8.2 Retail Pharmacy
  10.7.8.3 online Pharmacies and Others
  10.7.9 Historic and Forecast Market Size by Country
  10.7.9.1 Brazil
  10.7.9.2 Argentina
  10.7.9.3 Rest of SA

Chapter 11 Analyst Viewpoint and Conclusion
11.1 Recommendations and Concluding Analysis
11.2 Potential Market Strategies

Chapter 12 Research Methodology
12.1 Research Process
12.2 Primary Research
12.3 Secondary Research